ArticleRSC advances2023
Lead-free, formamidinium germanium-antimony halide (FA
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Investigation of Sr-doped ZnO electron transport layers for perovskite solar cells: a combined DFT and SCAPS-1D study.RSC advances · 2026Article
- Computational optimization of MASnIRSC advances · 2026Article
- Performance evaluation of EuRSC advances · 2025Article
- Computational modeling and photovoltaic performance evaluation of various ETL/HTL engineered CsCdIRSC advances · 2025Article
- Multiscale analysis of RbRSC advances · 2025Article
- Design and simulation of the potential of lead-free AgRSC advances · 2025Article
- Computational analysis of LiMgIRSC advances · 2025Article
- Numerical analysis of the MASnIRSC advances · 2025Article
- Enhancing Stability of Microwave-Synthesized CsChemSusChem · 2025Article
- Optimizing CsRSC advances · 2025Article
- The impact of CBz-PAI interlayer in various HTL-based flexible perovskite solar cells: A drift-diffusion numerical study.Heliyon · 2024Article
- Bandgap Engineering and Enhancing Optoelectronic Performance of a Lead-Free Double Perovskite CsACS omega · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Double halide perovskites have received massive attention due to their low toxicity, tunable bandgap, structural flexibility, and stability as compared to conventional 3D lead halide perovskites. Particularly, newly discovered formamidinium germanium-antimony halide (FA
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.